Medtronic announced CE (Conformité Européene) mark for the 26 and 29mm sizes of the CoreValve Evolut R System, a next-generation self-expanding valve for transcatheter aortic valve implantation (TAVI) providing the option to recapture and reposition the valve during procedures.

Ensuring that patients with peripheral arterial disease (PAD) get tested and treated with minimally invasive endovascular therapy saves legs and lives suggests a study in which amputation rates fell by nearly 80 percent after such a system was implemented.

A minimally invasive procedure to repair severe mitral valve regurgitation by clipping together the valve’s leaflets can improve function and quality of life and reduce the risk of hospitalization, research shows.

Case Western Reserve’s chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack.

United States hospitals began using a new medical device from Medtronic plc  called the In.Pact Admiral drug-coated balloon (DCB) to treat patients with peripheral arterial disease (PAD) in the upper leg. PAD is a common cardiovascular condition that causes leg pain and increases the risk of heart attack and stroke.

Patient Portals are a trending item in the healthcare industry, but what does the term "Patient Portal" really mean?

Medtronic announced a partnership agreement between its Cardiocom business and LHC Group.

Ostar Healthcare Technology announced the North American launch of their Cellular P201 telehealth blood pressure monitoring system. This advanced chronic disease remote monitoring system aids in reduction of 30-day readmission rates for heart patients, in particular those with congestive heart failure (CHF).

A new computer program allows doctors to assess blood flow as they are using flow-diverter devices to treat life-threatening aneurysms, suggests a preliminary study being presented at the 27th annual International Symposium on Endovascular Therapy (ISET).

EP lab, Implantable Cardioverter Defibrillators, Heart Failure

Boston Scientific Corporation announced the launch and first U.S. implant of its line of Extended Longevity (EL) implantable cardioverter defibrillators (ICD), including Dynagen EL and Inogen EL device models.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now